<DOC>
	<DOCNO>NCT02549469</DOCNO>
	<brief_summary>Bioequivalence trial healthy adult subject determine bioavailability 3 different sustain release formulation naproxen 660 mg relative establish commercial Aleve 220 mg tablet .</brief_summary>
	<brief_title>Bioequivalence Single Dose Extended Release Naproxen Sodium ( 660 mg ) Tablet Versus Naproxen Sodium ( 220 mg ) Tablet Three Times Daily</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>Healthy ambulatory male female subject 18 55 year age , inclusive Body Mass Index ( BMI ) approximately 18.0 30.0 kg/m2 , total body weight &gt; 50 kg ( 110 lb ) Results screen clinical laboratory test within normal limit consider clinically significant Principal Investigator Sponsor Female subject childbearing potential must use medically acceptable form birth control least 1 month prior screen ( 3 month oral contraceptive ) , e.g. , oral patch contraceptive , intrauterine device , intramuscular injection doublebarrier negative pregnancy test Screening Day 0 treatment period . Female subject nonchildbearing potential must amenorrheic least 2 year hysterectomy and/or bilateral oophorectomy . Provide personally sign date informed consent prior inclusion trial indicate subject inform pertinent aspects trial . History hypersensitivity aspirin ( ASA ) , naproxen sodium , acetaminophen , similar pharmacological agent component product History gastrointestinal bleeding perforation , include bleed related previous NSAID therapy . Active , history recurrent peptic ulcer/hemorrhage ( two distinct episode proven ulceration bleeding ) . Have take ASA , ASAcontaining product , acetaminophen ( acetylparaaminophenol APAP ) NSAID ( OTC prescription ) 7 day prior dose treatment period , study treatment Loss blood excess 500 mL within 56 day first dose trial treatment ( e.g. , donation , plasmapheresis , injury ) Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) Positive alcohol drug screen Screening Day 0 Treatment Periods 1 2 Females pregnant lactate Smokers currently consume type tobacco product ( ) include smoke cessation nicotinecontaining product ( eg , nicotine patch , nicotine gum ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>